Friday, January 20, 2023 1:12:04 PM
https://investmentbank.com/death-spiral/
My prediction is that Colbeck has set up the same scheme. No bank would EVER loan UNQL $25m. (TBK is a secured invoice debt facility.) UNQL couldn't even get $1m loans without convertible note financing through Trillium and 3a Capital. Those sharks got 25% of the company for $3.9m while Trillium made millions more selling hundreds of millions of converted shares to drive the price down while at the same time shorting and profiting more. History will repeat itself.
Because here's the alternative. Colbeck hypothetically actually gives UNQL $25m. Let's say 10% interest and a 10 year repayment. Here's the amortization calculator:
https://www.bankrate.com/mortgages/amortization-calculator/
That would be $4m a year in payments to total $14.5m in interest over 10 years. Don't forget, UNQL lost a million 3 years ago, made $1.7m 2 years ago, and lost another million last year. They should have no problem repaying $4m, no matter what, year after year after year. Yeah, sure.....
Death Spiral Toxic Financing is on the horizon. Don't say no one gave fair warning.
Recent UNQL News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 09:23:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 12:55:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:30:23 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 01/17/2024 09:23:29 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 10/31/2023 09:28:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 10:18:01 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/15/2023 10:02:56 AM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 08/30/2023 02:13:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2023 09:00:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM